precision medicine

R&D

an old woman and her middle-aged daughter image for a feature on ageing and neurological conditions

Ageing Europe - It’s time we prioritised neurological condit...

Europeans are living longer than ever before – tangible proof of the phenomenal advancements in science and healthcare.1,2 However, it comes with a paradoxical rise in nervous sy

News

DNA sequencer Element Bio raises $277m to take on Illumina

Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of

News

FDA widens label for BMS’ cancer drug Augtyro

Bristol-Myers Squibb has claimed FDA approval for a new, tumour-agnostic indication for Augtyro, the cancer drug it acquired as part of its $4.1 billion takeover of Turning Point Therapeuti

R&D

Looking to the future of clinical trials: Gene therapy, prec...

Next-generation technologies in medicine have significantly expanded our ability to identify and address rare diseases, propelling forwards the development of more effective and targeted tr

R&D

Accelerating the process, transforming therapies and advanci...

Next-generation technology is enabling drug discovery at an entirely new scale, accelerating the process, transforming therapies and advancing precision medicine, and resulting in better pa

Oncology